Suven Pharma might be the next pharma to move up.

Entry in Suven Pharma can be taken after closing above 508. Targets will be 536 and 555. Long term target in the company will be 598 and 633. Stop loss in the company should be considered at a closing below 455. Suven Pharmaceuticals Ltd. is a bio-pharmaceutical company which is engaged with the development and manufacturing chemical intermediaries. Negative are that FIIs are decreasing stake. Positives are followed by that they have low debt, zero promoter pledge, improving annual net profit.